Allogene Therapeutics shares owned by TD Asset Management
Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by TD Asset Management
from 13F filings
Historical chart of TD Asset Management investment in Allogene Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Allogene Therapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Allogene Therapeutics by TD Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $567k | 414k | 1.37 |
| 2025-09-30 | $514k | 414k | 1.24 |
| 2025-06-30 | $616k | 545k | 1.13 |
| 2025-03-31 | $796k | 545k | 1.46 |
| 2024-12-31 | $1.2M | 545k | 2.13 |
| 2024-09-30 | $2.0M | 677k | 2.91 |
| 2024-06-30 | $1.9M | 799k | 2.33 |
| 2024-03-31 | $2.0M | 437k | 4.47 |
| 2023-12-31 | $764k | 238k | 3.21 |
| 2023-09-30 | $754k | 238k | 3.17 |
| 2023-06-30 | $991k | 200k | 4.97 |
| 2023-03-31 | $858k | 174k | 4.94 |
| 2022-12-31 | $1.1M | 174k | 6.29 |
| 2022-09-30 | $1.7M | 165k | 10.32 |
| 2022-06-30 | $1.5M | 128k | 11.40 |
| 2022-03-31 | $1.1M | 122k | 9.11 |
| 2021-12-31 | $1.6M | 109k | 14.92 |
| 2021-09-30 | $2.9M | 111k | 25.70 |
| 2021-06-30 | $2.0M | 92k | 21.95 |
| 2021-03-31 | $2.9M | 82k | 35.30 |
| 2020-12-31 | $2.0M | 78k | 25.25 |
| 2020-09-30 | $2.9M | 78k | 37.71 |
| 2020-06-30 | $3.5M | 83k | 42.82 |
| 2020-03-31 | $1.1M | 54k | 19.44 |
| 2019-12-31 | $1.5M | 58k | 25.99 |
| 2019-09-30 | $1.6M | 58k | 27.25 |
| 2019-06-30 | $1.6M | 58k | 26.85 |
| 2019-03-31 | $741k | 26k | 28.90 |
| 2018-12-31 | $674k | 25k | 26.91 |